A South Bay biotech firm has bought a big San Jose office and research building in a deal that could enable the life sciences firm to expand its local operations considerably. Vibrant Wellness has ...

Discover the revival of the biotech sector, with IPOs resurging and promising weight loss drug potential, despite facing ...

DURHAM, N.C., Sept. 30, 2024 (GLOBE NEWSWIRE) -- (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract ...

Explore Estonia’s biotech scene with 7 pioneering companies across Tallinn, Tartu, and beyond, fueled by top science parks ...

As numerous trends are currently shaping what is an eventful year for the biotech industry, we have compiled a list of the top European biotech companies that have received sizable seed funding in the ...

Bob Duggan, 80, has gone from baking cookies to building robots, investing in biotech companies, and ranking among the ...

Heavily polluted water owing to illegal mining (galamsey) activities, is making it increasingly expensive for pharmaceutical ...

Scotiabank analyst George Farmer maintained a Buy rating on Legend Biotech (LEGN – Research Report) today and set a price target of ...

William Blair analyst Sami Corwin maintained a Hold rating on Legend Biotech (LEGN – Research Report) today. The company’s shares ...

Legend Biotech jumped Monday after the company said its J&J-tied multiple myeloma drug, Cavykti, cut the risk of death.

Many HCPs now place greater importance on pharmaceutical companies that integrate patients within the continuum of care.

Legend Biotech's valuation is conservative, suggesting potential for significant appreciation and growth ahead. Click here to ...